---
schema_version: "secwatch.filing_event.v1"
accession: "0001746473-23-000062"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2023-10-03T23:59:59+00:00"
generated_at: "2026-06-10T05:34:08.946811+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pliant Therapeutics signs 7-year lease for 100,904 sq ft in South San Francisco, terminates old lease

## Summary
- Leased 100,904 rentable sq ft at 331 Oyster Point Blvd, South San Francisco for 7-year initial term.
- Base rent starts at $0.26M/month in year 1 (based on phased rentable sq ft) and rises to $0.71M/month in year 7.
- Old lease at 260 Littlefield Ave will terminate 60 days after new lease commencement; no early termination penalties.
- Required $1.43M letter of credit; Tenant responsible for operating expenses and has 8-year extension option.
- Right of first offer on 33,333 sq ft on 2nd floor, subject to superior right of NGM Biopharmaceuticals.

## SEC filing metadata
- accession: 0001746473-23-000062
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2023-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/0001746473-23-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/plrx-20230928.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001746473-23-000062
- JSON: https://secwatch.observer/filing/0001746473-23-000062.json
- Plain text: https://secwatch.observer/filing/0001746473-23-000062.txt

## Key facts
- Material Agreements
  PLIANT THERAPEUTICS, INC. entered into Oyster Point Lease with HCP BTC, LLC valued at $0.26 million/month initial, $0.71 million/month final; 7 years; $1.43M letter of credit (effective 2023-09-28).
  - Action: entry
  - Agreement: lease
  - Counterparty: HCP BTC, LLC
  - Value: $0.26 million/month initial, $0.71 million/month final; 7 years; $1.43M letter of credit
  - Effective: 2023-09-28
  source text: On September 28, 2023, Pliant Therapeutics, Inc., a Delaware Corporation (the “Company”) entered into a lease agreement (the “Oyster Point Lease”) with HCP BTC, LLC, a Delaware limited liability company (the “Landlord”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/0001746473-23-000062-index.htm
- Material Agreements
  PLIANT THERAPEUTICS, INC. terminated Littlefield Lease Termination with Healthpeak OP, LLC valued at Termination 60 days after Oyster Point Lease commencement; no penalty (effective 2023-09-28).
  - Action: termination
  - Agreement: lease
  - Counterparty: Healthpeak OP, LLC
  - Value: Termination 60 days after Oyster Point Lease commencement; no penalty
  - Effective: 2023-09-28
  source text: In connection with the entry into the Oyster Point Lease, the Company entered into a termination agreement (the “Termination Agreement”) with Healthpeak OP, LLC, a Maryland limited liability company, successor-interest to HCP, Inc. (“Healthpeak”) with respect to the Company’s lease (the “Littlefield Lease”) of 260 Littlefield Avenue, South San Francisco, California 94080 (“Littlefield Premises”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1746473/000174647323000062/0001746473-23-000062-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.